Latest News
Vela Diagnostics Adds two SARS-CoV-2 Assays for Virus Genotyping, and Variant Identification to its COVID-19 Testing Solutions
26 February 2021 - - Singapore-based Vela Diagnostics has added ViroKey SQ FLEX SARS-CoV-2 Genotyping Assay and ViroKey SARS-CoV-2 ID RT-PCR Test to its portfolio offering, the company said.

The ViroKey SQ FLEX SARS-CoV-2 Genotyping Assa...
Tigermed Supported and Delivered Clinical Study of CanSino COVID-19 Vaccine as Clinical Contract Research Organization
26 February 2021 - - China National Medical Products Administration has granted conditional marketing authorization of Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector) (the "Ad5-nCoV," trade name: Convidecia), China-based clinic...
SARPAC Clinical Trial of Leukine in Hospitalized COVID-19 Patients Meets Primary Endpoint of Significant Improvement in Lung Function
26 February 2021 - - US-based Partner Therapeutics, Inc. has released top-line results of the investigator-led SARPAC (Sargramostim in Patients with Acute Hypoxic Respiratory Failure and Acute COVID-19) study of inhaled Leukine (s...
EMA Issues Advice on Regeneron's Antibody Cocktail for Certain COVID-19 Patients
26 February 2021 - - The European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion for US-based Regeneron Pharmaceuticals, Inc's (NASDAQ: REGN) investigational COVID-19 antibody cocktail (casir...
CHMP Adopts Positive Opinion for Evrysdi for the Treatment of Spinal Muscular Atrophy in Adults and Children Aged Two Months and Older
26 February 2021 - - The European Medicines Agency Committee for Medicinal Products for Human Use has recommended the approval of Evrysdi (risdiplam) for the treatment of 5q spinal muscular atrophy in patients 2 months and older, with a clinical diag...